Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype
Activation of cardiac fibroblasts and differentiation to myofibroblasts underlies development of pathological cardiac fibrosis, leading to arrhythmias and heart failure. Myofibroblasts are characterised by increased α-smooth muscle actin (α-SMA) fibre expression, secretion of collagens and changes i...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Springer Nature
2023
|
| _version_ | 1826313121322500096 |
|---|---|
| author | Hall, C Law, JP Reyat, JS Cumberland, MJ Hang, S Vo, NTN Raniga, K Weston, CJ O'Shea, C Townend, JN Gehmlich, K Ferro, CJ Denning, C Pavlovic, D |
| author_facet | Hall, C Law, JP Reyat, JS Cumberland, MJ Hang, S Vo, NTN Raniga, K Weston, CJ O'Shea, C Townend, JN Gehmlich, K Ferro, CJ Denning, C Pavlovic, D |
| author_sort | Hall, C |
| collection | OXFORD |
| description | Activation of cardiac fibroblasts and differentiation to myofibroblasts underlies development of pathological cardiac fibrosis, leading to arrhythmias and heart failure. Myofibroblasts are characterised by increased α-smooth muscle actin (α-SMA) fibre expression, secretion of collagens and changes in proliferation. Transforming growth factor-beta (TGF-β) and increased mechanical stress can initiate myofibroblast activation. Reversibility of the myofibroblast phenotype has been observed in murine cells but has not been explored in human cardiac fibroblasts. In this study, chronically activated adult primary human ventricular cardiac fibroblasts and human induced pluripotent stem cell derived cFbs (hiPSC-cFbs) were used to investigate the potential for reversal of the myofibroblast phenotype using either subculture on soft substrates or TGF-β receptor inhibition. Culture on softer plates (25 or 2 kPa Young's modulus) did not alter proliferation or reduce expression of α-SMA and collagen 1. Similarly, culture of myofibroblasts in the presence of TGF-β inhibitor did not reverse myofibroblasts back to a quiescent phenotype. Chronically activated hiPSC-cFbs also showed attenuated response to TGF-β receptor inhibition and inability to reverse to quiescent fibroblast phenotype. Our data demonstrate substantial loss of TGF-β signalling plasticity as well as a loss of feedback from the surrounding mechanical environment in chronically activated human myofibroblasts. |
| first_indexed | 2024-09-25T04:08:03Z |
| format | Journal article |
| id | oxford-uuid:df1ac95b-8247-4741-a908-77df85569f39 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:08:03Z |
| publishDate | 2023 |
| publisher | Springer Nature |
| record_format | dspace |
| spelling | oxford-uuid:df1ac95b-8247-4741-a908-77df85569f392024-06-04T11:44:20ZChronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotypeJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:df1ac95b-8247-4741-a908-77df85569f39EnglishSymplectic ElementsSpringer Nature2023Hall, CLaw, JPReyat, JSCumberland, MJHang, SVo, NTNRaniga, KWeston, CJO'Shea, CTownend, JNGehmlich, KFerro, CJDenning, CPavlovic, DActivation of cardiac fibroblasts and differentiation to myofibroblasts underlies development of pathological cardiac fibrosis, leading to arrhythmias and heart failure. Myofibroblasts are characterised by increased α-smooth muscle actin (α-SMA) fibre expression, secretion of collagens and changes in proliferation. Transforming growth factor-beta (TGF-β) and increased mechanical stress can initiate myofibroblast activation. Reversibility of the myofibroblast phenotype has been observed in murine cells but has not been explored in human cardiac fibroblasts. In this study, chronically activated adult primary human ventricular cardiac fibroblasts and human induced pluripotent stem cell derived cFbs (hiPSC-cFbs) were used to investigate the potential for reversal of the myofibroblast phenotype using either subculture on soft substrates or TGF-β receptor inhibition. Culture on softer plates (25 or 2 kPa Young's modulus) did not alter proliferation or reduce expression of α-SMA and collagen 1. Similarly, culture of myofibroblasts in the presence of TGF-β inhibitor did not reverse myofibroblasts back to a quiescent phenotype. Chronically activated hiPSC-cFbs also showed attenuated response to TGF-β receptor inhibition and inability to reverse to quiescent fibroblast phenotype. Our data demonstrate substantial loss of TGF-β signalling plasticity as well as a loss of feedback from the surrounding mechanical environment in chronically activated human myofibroblasts. |
| spellingShingle | Hall, C Law, JP Reyat, JS Cumberland, MJ Hang, S Vo, NTN Raniga, K Weston, CJ O'Shea, C Townend, JN Gehmlich, K Ferro, CJ Denning, C Pavlovic, D Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype |
| title | Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype |
| title_full | Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype |
| title_fullStr | Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype |
| title_full_unstemmed | Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype |
| title_short | Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype |
| title_sort | chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype |
| work_keys_str_mv | AT hallc chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT lawjp chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT reyatjs chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT cumberlandmj chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT hangs chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT vontn chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT ranigak chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT westoncj chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT osheac chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT townendjn chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT gehmlichk chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT ferrocj chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT denningc chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype AT pavlovicd chronicactivationofhumancardiacfibroblastsinvitroattenuatesthereversibilityofthemyofibroblastphenotype |